FDA green-lights Riverain x-ray software

The FDA has cleared Riverain Technologies Temporal Comparison x-ray software.

According to Dayton, Ohio-based Riverain, the software electronically compares current and prior chest x-ray images and notes differences between images of the same patient. The software aligns and registers the two patient images to produce a difference image.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.